137 results on '"Stachel, Georg"'
Search Results
2. Red blood cell distribution width (RDW) is associated with unfavorable functional outcome after transfemoral transcatheter aortic valve implantation
3. Fractal dimension of the aortic annulus: a novel predictor of paravalvular leak after transcatheter aortic valve implantation
4. Impact of Anesthesia Strategy and Valve Type on Clinical Outcomes After Transcatheter Aortic Valve Replacement
5. Left-Atrial Appendage Thrombosis in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation
6. Safety and Efficacy of Drug-Coated Balloons Versus Drug-Eluting Stents in Acute Coronary Syndromes: A Prespecified Analysis of BASKET-SMALL 2
7. Continued Versus Interrupted Oral Anticoagulation During Transfemoral Transcatheter Aortic Valve Implantation and Impact of Postoperative Anticoagulant Management on Outcome in Patients With Atrial Fibrillation
8. General versus Local Anesthesia with Conscious Sedation in Transcatheter Aortic Valve Implantation: The Randomized SOLVE-TAVI Trial
9. Gender-dependent association of diabetes mellitus with mortality in patients undergoing transcatheter aortic valve replacement
10. Impact of Insulin-Treated Compared to Non-Insulin-Treated Diabetes Mellitus on Outcome of Percutaneous Coronary Intervention with Drug-Coated Balloons versus Drug-Eluting Stents in De Novo Coronary Artery Disease: The Randomized BASKET-SMALL 2 Trial
11. Impact of moderate or severe left ventricular outflow tract calcification on clinical outcomes of patients with severe aortic stenosis undergoing transcatheter aortic valve implantation with self- and balloon-expandable valves: a post hoc analysis from the SOLVE-TAVI trial
12. TCT-370 Negative Compared to Positive Echocardiographic Imaging of Infective Endocarditis After Transcatheter Aortic Valve Implantation
13. Prognostic value of pre-interventional cerebral oxygen saturation in transcatheter aortic valve replacement: a prespecified secondary analysis of the SOLVE–TAVI trial
14. Long-Term Clinical and Echocardiographic Outcome After TAVR With the Mechanically Expanding Lotus Valve
15. Prognostic value of pre-interventional cerebral oxygen saturation in transcatheter aortic valve replacement: a prespecified secondary analysis of the SOLVE–TAVI trial
16. TCT-328 Improvement of TAVR Patient Outcome
17. Paravalvular Regurgitation According to Transcatheter Aortic Valve Prosthesis Type: Insights From the Randomized SOLVE-TAVI Trial
18. Impact of Diabetes on Outcome With Drug-Coated Balloons Versus Drug-Eluting Stents
19. Long-term Follow-up After Transcatheter Aortic Valve Replacement
20. Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial
21. Valve‐in‐Valve for Degenerated Transcatheter Aortic Valve Replacement Versus Valve‐in‐Valve for Degenerated Surgical Aortic Bioprostheses: A 3‐Center Comparison of Hemodynamic and 1‐Year Outcome
22. Comparison of newer generation self-expandable vs. balloon-expandable valves in transcatheter aortic valve implantation: the randomized SOLVE-TAVI trial
23. Treatment of failed aortic bioprostheses: An evaluation of conventional redo surgery and transfemoral transcatheter aortic valve-in-valve implantation
24. Outcome of patients with previous coronary artery bypass grafting and severe calcific aortic stenosis receiving transfemoral transcatheter aortic valve replacement
25. TCT-431 Impact of Tricuspid Regurgitation on TAVR Patient Outcome
26. TCT-712 Infective Endocarditis Caused by Staphylococcus or Enterococcus After Transcatheter Aortic Valve Implantation: A Comparison Between the 2 Most Common Microbiological Findings
27. TCT-764 Comparison of 3rd Generation Self-Expanding and Balloon-Expandable Devices in Valve in Valve Treatment of Failing Aortic Valve Bioprostheses
28. Outcome of patients with previous coronary artery bypass grafting and severe calcific aortic stenosis receiving transfemoral transcatheter aortic valve replacement.
29. Cardiac Surgery Compared With Antibiotics Only in Patients Developing Infective Endocarditis After Transcatheter Aortic Valve Replacement
30. TCT-296 Cardiac surgery compared to antibiotics only in patients developing infective endocarditis after transcatheter aortic valve replacement
31. TCT-649 Impact of postdilatation on long-term outcome and valve durability in TAVR patients
32. TCT-476 New Onset Atrial Fibrillation in Patients Undergoing Transfemoral Transcatheter Aortic Valve Replacement - Risk Factors and Outcome
33. TCT-334 Treatment of degenerated aortic bioprostheses: a comparison between valve-in-valve transfemoral transcatheter aortic valve replacement and conventional reoperation
34. Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial
35. TCT-336 Transfemoral TAVR Treatment of Failing Aortic Valve Bioprostheses - Mid Term Results and Outcome
36. Gender-dependent association of diabetes mellitus with mortality in patients undergoing transcatheter aortic valve replacement
37. Predictors of Mortality and Symptomatic Outcome of Patients With Low‐Flow Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement
38. Impact of active cancer disease on the outcome of patients undergoing transcatheter aortic valve replacement
39. TCT-399 Transfemoral Transcatheter Aortiv Valve Implantation Under Continued vs. Interrupted Oral Anticoagulation in Patients with Atrial Fibrillation
40. TCT-119 Short Term TAVR Outcome in Patients with Indication for Oral Anticoagulation
41. TCT-186 Impact of pulmonary hypertension on the outcome after transcatheter aortic valve implantation - results from a prospective single-center registry
42. TCT-790 Long-term follow-up after transcatheter aortic valve implantation and durability of transcatheter aortic valves - results of a prospective single-center registry
43. IMPACT OF CANCER DISEASE ON OUTCOME OF PATIENTS UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT
44. DIFFERENT IMPACT OF GENDER ON EARLY AND LATE OUTCOME AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT
45. TCT-705 Gender Impact on the Outcome after Transcatheter Aortic Valve Replacement
46. Incidence, Predictors, and Outcome of Patients Developing Infective Endocarditis Following Transfemoral Transcatheter Aortic Valve Replacement
47. TCT-682 Impact of concomitant mitral regurgitation on mortality after transcatheter aortic valve replacement for severe aortic stenosis in high risk patients – results from a prospective single center registry
48. TCT-664 Prognostic Impact of Pacemaker Implantation after Transfemoral/Trancutaneous Aortic Valve Implantation – Lessons from a Large Single Centre Registry
49. Impact of active cancer disease on the outcome of patients undergoing transcatheter aortic valve replacement.
50. BASICS Physik
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.